Lubarsky D A, Hahn C, Bennett D H, Smith L R, Bredehoeft S J, Klein H G, Reves J G
Department of Anesthesiology, Duke University Medical Center, Durham 27710.
Anesth Analg. 1994 Oct;79(4):629-37. doi: 10.1213/00000539-199410000-00003.
We sought to determine the actual cost to Duke University Medical Center of a perioperative red blood cell transfusion. A recent audit at Duke University Medical Center determined the base average direct and indirect hospital costs for providing a unit of red blood cells. The Transfusion Service's base cost for providing an allogeneic unit of red blood cells was $113.58. To obtain the actual hospital cost of transfusing a unit of red blood cells in the perioperative period, associated costs were calculated and added to the Transfusion Service's base cost. These associated costs included compatibility tests on multiple units per each unit transfused in the perioperative period, performing ABO and Rh typing and antibody screening on samples from patients who were not subsequently transfused, compatibility tests on units not issued, handling costs of units issued but not used, physically administering the blood, and the cost of the recipient contracting an infectious disease or developing a transfusion reaction. These associated costs increased the cost of transfusing an allogeneic unit of red blood cells in the perioperative period to $151.20. Perhaps the techniques described in the study can be used to quantify cost/benefit ratios associated with future changes in transfusion practice.
我们试图确定杜克大学医学中心围手术期红细胞输血的实际成本。杜克大学医学中心最近的一次审计确定了提供一个单位红细胞的基础平均直接和间接医院成本。输血服务部门提供一个单位异体红细胞的基础成本为113.58美元。为了获得围手术期输注一个单位红细胞的实际医院成本,计算了相关成本并将其加到输血服务部门的基础成本上。这些相关成本包括对围手术期每输注一个单位红细胞所需的多个单位进行相容性检测、对随后未输血患者的样本进行ABO和Rh血型鉴定及抗体筛查、对未发放单位进行相容性检测、已发放但未使用单位的处理成本、实际输血成本,以及受血者感染传染病或发生输血反应的成本。这些相关成本使围手术期输注一个单位异体红细胞的成本增加到151.20美元。或许该研究中描述的技术可用于量化与未来输血实践变化相关的成本效益比。